Aiforia Technologies Plc, Company release, 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development.
Aiforia Technologies Plc, Press Release, 04 April 2023 at 12:00 a.m. EEST. The first NHS Trust of the PathLAKE Plus consortium has signed an individual contract to adopt Aiforia PD-L1 AI model for lung cancer in clinical diagnostics. The duration of the contract is three years, with a possible three-year extension.
Aiforia Technologies Plc appoints a new Vice President of Marketing who brings international experience in various commercial positions both in the field of tissue diagnostics and targeted therapies for cancer.